ADHD and Bipolar Disorder in Adulthood: Clinical and Treatment Implications

Adults with ADHD and Bipolar Disorder

By: Dr Philip Bird the Gosforth Clinic, Australia.

A review of ADHD and Bipolar Disorder for the clinician who is often be faced with the management of these complex patients.

ADHD and Bipolar Disorder in Adulthood: Clinical and Treatment Implications

By: Virginio Salvi, Enrico Ribuoli, Michele Servasi, Laura Orsolini, Umberto Volpe.

https://pubmed.ncbi.nlm.nih.gov/34068605/

Abstract:
Attention deficit hyperactivity disorder (ADHD) is a condition that usually has its onset in childhood. Although the disorder persists into adulthood in half of cases, adult ADHD is often not recognized due to different psychopathological characteristics, quite often overlapping with other diagnoses such as mood, anxiety and personality disorders. This is especially true for bipolar disorder (BD), which shares several symptoms with adult ADHD. Moreover, besides an overlapping clinical presentation, BD is often co-occurring in adults with ADHD, with comorbidity figures as high as 20%. This review will focus on the comorbidity between ADHD and BD by exploring the magnitude of the phenomenon and evaluating the clinical and functional characteristics associated with ADHD-BD comorbidity in adults. Finally, the review will address the implications of pharmacologically treating the ADHD-BD comorbidity, providing suggestions in how to treat these complex patients and addressing the issue of treatment-induced manic switch with the use of stimulants and other medications for ADHD.

Short Comment:
Bipolar disorder (BD) is characterized by the alternation of mood episodes and euthymia leading to impaired functioning and quality of life. Several symptoms encountered in ADHD are common in BD, particularly during elated phases. However, differences in the phenomenology of the two disorders can assist clinicians in separating these conditions. These include the core ADHD dimension of inattention which is frequently reported as a wandering of thought whereas during elevated episodes it is often the pace of thoughts which leads to increased distractibility. Further, BD symptoms fluctuate over time in contrast to their consistency in ADHD. Other clinical characteristics of these two conditions are also reviewed including the intra-episode sleep disturbance during elevated episode reflecting a reduced need to sleep whereas in ADHD it is accompanied by distress and fatigue.

The underlying timeline of these conditions are emphasised with the BD having an oscillating course with distinct phases and ADHD being consistent over time. The age onset is also different with the first symptoms of ADHD usually occurring before age 12 and BD peaking in late adolescence or early adulthood.

This review concluded that 10 – 20% of adult patients with BD have comorbid ADHD with even higher rates associated with an earlier onset. Additionally, youths with ADHD were more at risk to develop BD in young adulthood with incident rates of 7 – 21% and that the comorbidity between ADHD and BD appeared to be a negative prognostic feature.

The comorbid ADHD and BD are a critical group of patients who experience a lower quality of life, increased mood episodes, prevalence of substance abuse and dependence. In spite of this severe clinical picture only a few studies have investigated the best treatment modalities for these complex patients. With this in mind the authors considered that their treatment recommendations should be considered as preliminary. When ADHD and BD co-occur, mood stabilization should be the first goal of treatment. When a mood stabilizer is in place, the augmentation with stimulant medications is effective in ameliorating the ADHD symptomatology. Although the possibility of a treatment-emergent (hypo) manic switch should be taken into account, it is uncommon when proper mood stabilization is in place.